Rainer Strohmenger
Direktor/Vorstandsmitglied bei AMBOSS GmbH
Ursprung des Netzwerks ersten Grades von Rainer Strohmenger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Wellington Partners GmbH
 Wellington Partners GmbH Investment ManagersFinance Wellington Partners GmbH (Wellington Partners) is an independent venture capital firm founded in 1991 by Rolf Christof Dienst. The firm is headquartered in Munich, with offices in Zurich, London, and Palo Alto.
36
| Private Company | Investment Managers | 36 |
Quanta Dialysis Technologies Ltd.
 Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom.
12
| Holding Company | Medical Specialties | 12 |
11
| Public Company | Medical Specialties | 11 |
iOmx Therapeutics AG
 iOmx Therapeutics AG BiotechnologyHealth Technology iOmx Therapeutics AG develops immunotherapy treatments for cancer patients. It specializes in immuno oncology, drug development and cancer therapy. The company was founded by Nisit Khandelwal, Philipp Beckhove, Patrick Baeuerle, Sebastian Meier-Ewert and Elmar Maier in March 2016 and is headquartered in Munich, Germany.
10
| Holding Company | Biotechnology | 10 |
AMBOSS GmbH
 AMBOSS GmbH Miscellaneous Commercial ServicesCommercial Services AMBOSS GmbH owns and operates a web based platform for training physicians. It specializes in medicine, medical knowledge, health, medical students, e-learning, and clinical decision support. The company was founded by Kenan Hasan, Madjid Salimi and Sievert Weiss in November 2011 and is headquartered in Berlin, Germany.
3
| Holding Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Rainer Strohmenger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| STRYKER CORPORATION | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
HBM Partners AG
 HBM Partners AG Investment ManagersFinance HBM Partners AG (HBM-P) was established in 2001 as an independent provider of investment advisory services with headquarters in Zug, Switzerland. HBM-P's field of expertise comprises global human medicine, biotechnology, medical technology and related sectors. The firm primarily advises HBM BioVentures AG and HBM BioCapital via their Cayman Islands-based, wholly-owned subsidiary, HBM Partners (Cayman) Ltd., which acts as the investment manager for the HBM funds. They rely on the services of an external consultant to analyze investment opportunities in the US. | Investment Managers | Private Equity Investor Private Equity Investor | |
eWise Group, Inc.
 eWise Group, Inc. Packaged SoftwareTechnology Services eWise Group, Inc. provides financial software solutions. It products include money manager, personal data vault, connected insights and resources. The company was founded by Alexander Grinberg in 2000 and is headquartered in Centennial, CO. | Packaged Software | Director/Board Member Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Investment Committee Member | |
| The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin | |
| MORPHOSYS AG | Biotechnology | Chairman Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of California, Berkeley | College/University | Graduate Degree Masters Business Admin | |
| Technische Universität München | College/University | Doctorate Degree Doctorate Degree | |
EnOcean GmbH
 EnOcean GmbH Electronic Production EquipmentElectronic Technology EnOcean GmbH develops and provides patented self-powered wireless technology. It manufactures and markets maintenance-free wireless sensor solutions for use in buildings and industrial installations. The firm's solutions are based on miniaturized energy converters, ultra-low-power electronic circuitry, and reliable wireless. Its products include accessories, software and firmware. The company was founded by Andreas Schneider and Frank Schmidt in 2001 and is headquartered in Oberhaching, Germany. | Electronic Production Equipment | Director/Board Member Director/Board Member Director/Board Member | |
Horizon Therapeutics Switzerland GmbH
 Horizon Therapeutics Switzerland GmbH Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Schweiz GmbH is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company was originally founded in 2004 as a spin-out of Merck KGaA and is headquartered in Reinach, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Swyx Solutions GmbH
 Swyx Solutions GmbH Packaged SoftwareTechnology Services Swyx Solutions GmbH develops and provides software based internet protocol telephony solutions. Its products include unified communications and case studies, third party products and SIP-provider. The firm also offers communication software, phones, protocol and update services. The company was founded by Wolfgang Schröder, Ralf Ebbinghaus, Uwe Sauerbrey and Frank Heidemann in 1999 and is headquartered in Dortmund, Germany. | Packaged Software | Director/Board Member Chairman | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Undergraduate Degree Director/Board Member | |
| Technical University of Berlin | College/University | Graduate Degree Doctorate Degree | |
| Freie Universität Berlin | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
| University of Geneva | College/University | Doctorate Degree Doctorate Degree | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree | |
Cavendish Kinetics, Inc.
 Cavendish Kinetics, Inc. SemiconductorsElectronic Technology Cavendish Kinetics, Inc. provides radio frequency tuning solutions for mobile devices in the wireless industry. It is a fabless supplier of tunable components for RF circuits used in cellular handsets, laptops, netbooks, tablets, and other consumer wireless devices. The firm offers tunable RF circuits, based on third-generation RF MEMS technology and its semiconductor processes, let users pack more performance into the same space. The company was founded by Charles Gordon Smith and Hermann M. Hauser in 1994 and is headquartered in San Jose, CA. | Semiconductors | Director/Board Member Director/Board Member | |
MIG Verwaltungs AG
 MIG Verwaltungs AG Investment ManagersFinance MIG Verwaltungs AG is a private equity investment firm headquartered in Munich, Germany. It was founded in 2004 by entrepreneurs and financial institutions, to follow up on the success of the venture capital investment vehicles Global Chance Fund and Global Asset Fund, with which MIG's management had been involved. | Investment Managers | Private Equity Investor Private Equity Investor | |
| EOS IMAGING | Medical Specialties | Director/Board Member Director/Board Member | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOPHYTIS S.A. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Polaris SA /FR/
 Polaris SA /FR/ Pharmaceuticals: MajorHealth Technology Polaris SA engages in the biotechnology industry and specializes in the field of healthy omega 3 lipids. The company was founded by St?phane Lozachmeur and Gildas Breton on July 1, 1994 and is headquartered in Quimper, France. | Pharmaceuticals: Major | Director/Board Member Chairman | |
agnion Energy, Inc.
 agnion Energy, Inc. Alternative Power GenerationUtilities agnion Energy, Inc. supplies local bio-energy plants and specializes in transforming solid biomass into electricity and heat. The firm utilizes its patented Heatpipe-Reformer technology, which enables wood-based biomass to be converted into synthetic gas. Its decentralized plants can both produce synthetic natural gas (SNG) and hydrogen as well as support heat and power cogeneration. The company was founded in 2007 and is headquartered in Wilmington, DE. | Alternative Power Generation | Director/Board Member Director/Board Member | |
GLO AB
 GLO AB SemiconductorsElectronic Technology GLO AB operates as a holding company. It develops technologies to fabricate defect-free, single-crystal semiconductor nanowire structures, with direct control of morphology and chemical composition. The firm focuses on the development and commercialization of light-emitting diode products using nanotechnology. Its products can be use in display, automotive and illumination application. The company was founded by Lars Ivar Samuelson, Steven Alan Morrell and Jonas Björn Ohlsson on February 25, 2003 and is headquartered in Lund, Sweden. | Semiconductors | Chairman Director/Board Member | |
Kurma Partners SA
 Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| Wellington Partners Advisory AG | Corporate Officer/Principal Director of Finance/CFO | ||
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chairman Director/Board Member | |
Personal MedSystems GmbH
 Personal MedSystems GmbH Medical/Nursing ServicesHealth Services Personal MedSystems GmbH provides healthcare services. The firm offers diagnostics services. It serves the health care industry. The company was founded by Felix Brand and Markus Riemenschneider on June 27, 2008 and is headquartered in Berlin, Germany. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
coramaze technologies GmbH
 coramaze technologies GmbH Medical SpecialtiesHealth Technology coramaze technologies GmbH operates as a medical device company which develops valve repair system. It offers mitramaze a novel concept for transcatheter mitral valve repair intended for treatment of inoperable patients suffering from severe functional mitral regurgitation. The company was founded by Laura Figulla and Till Neumann in 2013 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
| MEDTRONIC PLC | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Implanet America, Inc.
 Implanet America, Inc. Medical SpecialtiesHealth Technology Part of Implanet SA, Implanet America, Inc. designs and manufactures surgical implants. The company is based in Boston, MA. | Medical Specialties | Corporate Officer/Principal Treasurer Chairman | |
Imcheck Therapeutics SAS
 Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Imcheck Therapeutics SAS operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research. The company was founded by Olive Daniel in 2015 and is headquartered in Marseille, France. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CULLINAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Founder | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member Director/Board Member | |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistik
International
| Vereinigte Staaten | 17 |
| Deutschland | 17 |
| Frankreich | 11 |
| Schweiz | 5 |
| Schweden | 3 |
Sektoral
| Health Technology | 19 |
| Consumer Services | 12 |
| Finance | 10 |
| Electronic Technology | 5 |
| Technology Services | 4 |
Operativ
| Director/Board Member | 456 |
| Corporate Officer/Principal | 114 |
| Chairman | 86 |
| Private Equity Investor | 70 |
| Independent Dir/Board Member | 63 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Emmanuel Fiessinger | 52 |
| Leslie Norwalk | 46 |
| Philippe Peltier | 45 |
| Eric Archambeau | 43 |
| Regina Hodits | 34 |
| Bo Jesper Hansen | 34 |
| Jan Hendrik Egberts | 33 |
| Gerald Heinz Möller | 29 |
| Meghan Fitzgerald | 28 |
| Anthony Adam Rosenberg | 23 |
| Albert Joseph Markus | 22 |
| Chandra Paul Leo | 22 |
| Stuart Essig | 21 |
| Aniruddha Nazre | 21 |
| Jean-Gérard Galvez | 21 |
- Börse
- Insiders
- Rainer Strohmenger
- Unternehmensverbindungen
